← Open Payments lookup

NPI 1700414240: Open Payments

NPI 1700414240. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$183 in 8 payments from 1 company in 2025. Trend: 2023 $315 · 2024 $0 · 2025 $183

Food & beverage: $183
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$183

Products named: INGREZZA.